Clinical Trial Update: Feasibility of [11C]Acetate-PET in LAM and TSC [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 feasibility study evaluating [11C]Acetate-PET imaging in lymphangioleiomyomatosis and tuberous sclerosis complex. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioleiomyomatosis
• Tuberous Sclerosis Complex

Drugs mentioned

• [11C]Acetate-PET imaging tracer

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Lymphangioleiomyomatosis, Tuberous Sclerosis Complex | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-01-21